[1]Mehrotra R,Singh M,Kumar D,et al.Age specific incidence rate and pathological spectrum of oral cancer in Allahabad[J].Indian J Med Sci,2003,57(9):400-404.[2]Lokeshwar VB, Schroeder GL, Carey RI,et al.Regulation of hyaluronidase activity by alternative mRNA splicing[J].J Biol Chem,2002,277(37):33654-33663.[3]Isoyama T, Thwaites D, Selzer MG,et al.Differential selectivity of hyaluronidase nhibitors toward acidic and hasic hyahronidases[J].Glycobiology,2006,16(1):11-21.[4]Itano N, Atsumi F, Sawai T, et al.Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration[J].Proc Natl Acad Sci U S A,2002,99(6):3609-3614.[5]Stern R, Shuster S, Wiley TS, et al.Hyaluronidase can modulate expression of CD44[J].Exp Cell Res,2001,266(1):167-176.[6]Franzmann EJ, Schroeder GL, Goodwin WJ, et al.Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors[J].Int J Cancer,2003,106(3):438-445.[7]王敬旭,刘海潮,廖贵清.口腔鳞状细胞癌患者唾液中透明质酸酶的活性分析[J].国际口腔医学杂志,2009,36(4):398-400.[8]Lobmayr L, Sauer T, Killisch I, et al.Transferrin receptor hyperexpression in primary erythroblasts is lost on transformation by avian erythroblastosis virus[J].Blood,2002,100(1):289-298.[9]Daniels TR, Delgado T, Rodriguez JA,et al.The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer[J].Clin Immunol,2006,121(2):144-158.[10]Jou YJ, Lin CD, Lai CH,et al.Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer[J].Anal Chim Acta,2010,681(1-2):41-48.[11]Guo T, Rudnick PA, Wang W,et al.Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS[J].J Proteome Res,2006,5(6):1469-1478.[12]Nagler RM.Saliva as a tool for oral cancer diagnosis and prognosis[J].Oral Oncol,2009,45(12):1006-1010.[13]Watanabe T, Suzuki N, Shimamoto N,et al.Contribution of endogenous endothelin to the extension of myocardial infarct size in rats[J].Circ Res,1991,69(2):370-377.[14]Hoffmann RR, Yurgel LS, Campos MM.Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia[J].Regul Pept,2011,166(1-3):55-58.[15]Bhalla A, Haque S, Taylor I,et al.Endothelin receptor antagonism and cancer[J].Eur J Clin Invest,2009,39(Suppl 2):74-77.[16]Pickering V, Jordan RC, Schmidt BL.Elevated salivary endothelin levels in oral cancer patients--a pilot study[J].Oral Oncol,2007,43(1):37-41.[17]Gakhar L, Bartlett JA, Penterman J, et al.PLUNC is a novel airway surfactant protein with anti-biofilm activity[J].PLoS One.,2010,5(2):e9098-.[18]Zhou HD, Fan SQ, Zhao J,et al.T3 distribution of the secretory protein, SPLUNC1, in the human fetus[J].Histochem Cell Biol.,2006,125(3):315-324.[19]Vargas PA, Speight PM, Bingle CD, et al.Expression of PLUNC family members in benign and malignant salivary gland tumours[J].Oral Dis,2008,14(7):613-619.[20]Vidotto A, Henrique T, Raposo LS, et al.Salivary and serum proteomics in head and neck carcinomas: before and after surgery and radiotherapy[J].Cancer Biomark,2010,8(2):95-107.[21]Guerrero-Preston R, Soudry E, Acero J, et al.NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma t7s and saliva[J].Cancer Prev Res (Phila),2011,4(7):1061-1072.[22]Jones PA, Baylin SB.The fundamental role of epigenetic events in cancer[J].Nat Rev Genet,2002,3(6):415-428.[23]Ehrlich M, Gama-Sosa MA, Huang LH, et al.Amount and distribution of 5-methylcytosine in human DNA from different types of t8s of cells[J].Nucleic Acids Res,1982,10(8):2709-2721.[24]López M, Aguirre JM, Cuevas N, et al.Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool?[J].Eur J Cancer,2003,39(16):2306-2309.[25]Righini CA, de Fraipont F, Timsit JF,et al.Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence[J].Clin Cancer Res,2007,13(4):1179-1185.[26]Viet CT, Schmidt BL.Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients[J].Cancer Epidemiol Biomarkers Prev,2008,17(12):3603-3611.[27]Righini CA, de Fraipont F, Timsit JF,et al.Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence[J].Clin Cancer Res,2007,13(4):1179-1185.[28]Wu JY, Yi C, Chung HR,et al.Potential biomarkers in saliva for oral squamous cell carcinoma[J].Oral Oncol,2010,46(4):226-231.[29]Li Y, St John MA, Zhou X, et al.Salivary transcriptome diagnostics for oral cancer detection[J].Clin Cancer Res,2004,10(24):8442-8450.[30]Brinkmann O, Kastratovic DA, Dimitrijevic MV, et al.Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population[J].Oral Oncol,2011,47(1):51-55.[31]Park NJ, Zhou H, Elashoff D, et al.Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection[J].Clin Cancer Res,2009,15(17):5473-5477.[32]Carrington JC, Ambros V.Role of microRNAs in plant and animal development[J].Science,2003,301(5631):336-338.[33]Lu J, Getz G, Miska EA, et al.MicroRNA expression profiles classify human cancers[J].Nature,2005,435(7043):834-838. |